Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 11/20 | 0.70 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.70 |
| ▸ | NPY1R | P25929 | 1/20 | 0.65 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.65 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.64 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.64 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.64 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Neurotensin SCHEMBL29851748 | 1.00 | NTSR1 (0.70) | NTSR1NTSR2NPY1RSORT1OPRD1 | |
| SCHEMBL30102522 | 0.98 | NTSR1 (0.70) | NTSR1NTSR2NPY1RSORT1OPRD1 | |
| SCHEMBL30446151 | 0.94 | NMUR2 (0.67) | NTSR1NTSR2NPY1RNMUR2 | |
| SCHEMBL30957024 | 0.92 | KDM1A (0.61) | NTSR1NTSR2NPY1RSORT1 | |
| Neurotensin SCHEMBL30483709 | 0.92 | KDM1A (0.61) | NTSR1NTSR2NPY1RSORT1 | |
| SCHEMBL29361023 | 0.86 | NTSR1 (0.74) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL29402893 | 0.86 | HCRTR1 (0.68) | NTSR1NPY1ROPRD1OPRM1OPRK1 | |
| SCHEMBL31302260 | 0.86 | KDM1A (0.58) | NPY1ROPRD1 | |
| SCHEMBL38650581 | 0.86 | KDM1A (0.62) | NPY1ROPRM1OPRK1NMUR2 | |
| SCHEMBL29930119 | 0.84 | NTSR1 (0.87) | NTSR1NTSR2NPY1RSORT1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2384 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116036309-B | Layered double hydroxide material system and preparation method and application thereof | Shanghai Teyijie Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| WO-2026090085-A1 | TREATMENT OF CD33 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-3532092-B1 | IMMUNOGLOBULINS AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2026-04-29 | — | — | EP | claimed |
| US-12611379-B2 | Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof | SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE (CN) | 2026-04-28 | — | — | US | claimed |
| EP-4728279-A2 | USE OF CUSTOM-DESIGNED PEPTIDES FOR MASS CALIBRATION | DH Technologies Development Pte. Ltd. (SG) | 2026-04-22 | — | — | EP | claimed |
| US-20260083820-A1 | METHOD FOR AMELIORATING AUTISM SYMPTOMS BY PHARMACOLOGICAL ACTIVATION OF THE NEUROTENSIN RECEPTOR 1 (NTSR1) | NEW YORK INSTITUTE OF TECHNOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| EP-4688849-A1 | BLOOD-BRAIN BARRIER CROSSING ANTIBODIES | VIB VZW (BE) | 2026-02-11 | — | — | EP | claimed |
| US-12474353-B2 | Methods and materials for assessing and treating obesity | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2025-11-18 | — | — | US | claimed |
| WO-2025235433-A1 | ENGINEERED MICROBES AS DELIVERY VEHICLES OF MODULATORY MOLECULES OF THE ENTEROENDOCRINE SYSTEM | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250345446-A1 | BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES | DRAUPNIR BIO APS (DK) | 2025-11-13 | — | — | US | claimed |
| US-20220133839-A1 | PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S) | TXP PHARMA GMBH (CH) | 2022-05-05 | — | — | US | claimed |
| EP-3988580-A2 | HYDROGEL INCLUSION COMPLEX CONTAINING BIOACTIVE SUBSTANCE BOUND TO TEMPERATURE-SENSITIVE POLYPHOSPHAZENE BY HOST-GUEST INTERACTION THROUGH BETA-CYCLODEXTRIN, AND USE THEREOF | Korea Institute of Science and Technology (KR) | 2022-04-27 | — | — | EP | claimed |
| CN-114306547-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of pregnant women | 华子昂 | 2022-04-12 | — | — | CN | claimed |
| CN-114306550-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of perimenopausal women | 刘敏如女科医系研究院(深圳)有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114272323-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of lactating women | 华子昂 | 2022-04-05 | — | — | CN | claimed |
| CN-114272321-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of old people | 华子昂 | 2022-04-05 | — | — | CN | claimed |
| CN-114272335-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of children | 华子昂 | 2022-04-05 | — | — | CN | claimed |
| CN-114269391-A | Hydrogel inclusion complexes comprising physiologically active substances bound to thermosensitive poly (phosphazene) through host-guest interactions using beta-cyclodextrin and uses thereof | 韩国科学技术研究院 | 2022-04-01 | — | — | CN | claimed |
| US-11261164-B2 | Small molecule agonists of neurotensin receptor 1 | Sanford Burnham Prebys Medical Discovery Institute (US) | 2022-03-01 | — | — | US | claimed |
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | claimed |